Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Raw Materials (2016 - 2026)

Standard Biotools has reported Raw Materials over the past 15 years, most recently at $8.6 million for Q4 2025.

  • Quarterly Raw Materials fell 33.82% to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.6 million through Dec 2025, down 33.82% year-over-year, with the annual reading at $8.6 million for FY2025, 33.82% down from the prior year.
  • Raw Materials was $8.6 million for Q4 2025 at Standard Biotools, down from $12.5 million in the prior quarter.
  • Over five years, Raw Materials peaked at $50.0 million in Q3 2024 and troughed at $8.6 million in Q4 2025.
  • The 5-year median for Raw Materials is $12.8 million (2022), against an average of $18.2 million.
  • Year-over-year, Raw Materials surged 192.67% in 2024 and then tumbled 80.09% in 2025.
  • A 5-year view of Raw Materials shows it stood at $9.3 million in 2021, then soared by 80.48% to $16.9 million in 2022, then decreased by 22.68% to $13.0 million in 2023, then changed by 0.0% to $13.0 million in 2024, then plummeted by 33.82% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Raw Materials are $8.6 million (Q4 2025), $12.5 million (Q3 2025), and $9.8 million (Q2 2025).